Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	40993
Country	United States

Received	2018-07-19 01:14
Peer-Review Started	2018-07-19 12:55
To Make the First Decision	2018-08-03 01:16
Return for Revision	2018-08-07 02:21
Revised	2018-08-07 16:45
Second Decision	2018-08-10 08:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2018-08-13 00:52
Articles in Press	2018-08-13 00:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-10-11 13:37
Publish the Manuscript Online	2018-10-15 12:09

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis
Manuscript Source	Invited Manuscript
All Author List	Jennifer L Leiting and Travis E Grotz
ORCID	Author(s) ORCID Number Jennifer L Leiting http://orcid.org/0000-0002-5784-7937 Travis E Grotz http://orcid.org/0000-0002-7753-097X
Funding Agency and Grant Number
Corresponding Author	Travis E Grotz, MD, Surgical Oncologist, Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, 200 First St Southwest, Rochester, MN 55905, United States. grotz.travis@mayo.edu
Key Words	Peritoneal carcinomatosis index; Peritoneal carcinomatosis; Gastric cancer; Cytoreductive surgery; Heated intraperitoneal chemotherapy; Neoadjuvant intraperitoneal and systemic chemotherapy
Core Tip	Peritoneal carcinomatosis (PC) from gastric cancer, along with positive peritoneal cytology, are associated with poor overall outcomes. The treatment of patients with this disease burden has greatly improv­ed and new multimodality treatment regimens have been introduced. Some of these include neoadjuvant laparoscopic heated intraperitoneal chemotherapy and bidirectional therapies like neoadjuvant intraperitoneal and systemic therapy. Appropriate patient selection remains crucial for optimal outcomes but we can be optimistic about the prospects for carefully selected patients with PC from gastric cancer.
Publish Date	2018-10-15 12:09
Citation	Leiting JL, Grotz TE. Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis. World J Gastrointest Oncol 2018; 10(10): 282-289
URL	http://www.wjgnet.com/1948-5204/full/v10/i10/282.htm
DOI	http://dx.doi.org/10.4251/wjgo.v10.i10.282

Full Article (PDF)	WJGO-10-282.pdf
Full Article (Word)	WJGO-10-282.doc
Manuscript File	40993-Review.docx
Answering Reviewers	40993-Answering reviewers.pdf
Audio Core Tip	40993-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	40993-Conflict-of-interest statement.pdf
Copyright License Agreement	40993-Copyright license agreement.pdf
Peer-review Report	40993-Peer-review(s).pdf
Scientific Misconduct Check	40993-Scientific misconduct check.pdf
Scientific Editor Work List	40993-Scientific editor work list.pdf